[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551026":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":41,"centralContacts":46,"locations":55,"responsibleParty":81,"collaborators":50,"id":84,"slug":85,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":50,"eligibilityCriteria":90,"healthyVolunteers":86,"sex":91,"minAge":92,"maxAge":50,"enrollmentInfo":93,"targetDuration":50,"studyType":96,"phases":97,"briefSummary":99,"conditions":100,"keywords":50,"overallStatus":57,"whyStopped":50,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":111},{"fullName":5,"class":6},"Parc de Salut Mar","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"DLT + ESWT","EXPERIMENTAL","To DLT + ESWT group, decongestive lymphatic therapy (DLT) plus radial extracorporeal wave treatment (ESWT) will be applied, at a dose and intensity probed to be useful to diminish volume in upper limb lymphedema.",[13,14],"Device: Extracorporeal shock wave therapy by radial device","Other: DLT",{"label":16,"type":17,"description":18,"interventionNames":19},"DLT + Sham ESWT","SHAM_COMPARATOR","To DLT + Sham ESWT group, decongestive lymphatic therapy plus sham radial extracorporeal wave treatment will be applied, at a placebo dose and intensity.",[20,14],"Device: Placebo extracorporeal shock wave therapy by radial device",[22,30,35],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"DEVICE","Extracorporeal shock wave therapy by radial device","Patients will receive treatment by extracorporeal shock waves therapy (ESWT).",[9],[28,29],"Radial ESWT","rESWT",{"type":23,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"Placebo extracorporeal shock wave therapy by radial device","Patients will receive treatment sham extracorporeal shock waves.",[16],[28,29],{"type":6,"name":36,"description":37,"armGroupLabels":38,"otherNames":39},"DLT","Patients will receive treatment with decongestive lymphatic therapy (DLT: manual lymphatic drainage, compression)",[9,16],[40],"Decongestive Lymphatic Therapy",[42],{"name":43,"affiliation":44,"role":45},"Roser Belmonte, MD, PhD","Hospital del Mar","PRINCIPAL_INVESTIGATOR",[47,52],{"name":43,"role":48,"phone":49,"phoneExt":50,"email":51},"CONTACT","+34 933674214",null,"rbelmonte@psmar.cat",{"name":53,"role":48,"phone":49,"phoneExt":50,"email":54},"Esther Duarte, MD, PhD","eduarte@psmar.cat",[56],{"facility":44,"status":57,"city":58,"state":50,"zip":59,"country":60,"countryCode":61,"cosmosGeoPoint":62,"geoPoint":67,"contacts":68},"RECRUITING","Barcelona","08003","Spain","ES",{"type":63,"coordinates":64},"Point",[65,66],2.15899,41.38879,{"lat":66,"lon":65},[69,72,74,77,79],{"name":70,"role":48,"phone":71,"phoneExt":50,"email":54},"Esther Duarte, PhD","933674214",{"name":73,"role":48,"phone":71,"phoneExt":50,"email":51},"Roser Belmonte, PhD",{"name":75,"role":76,"phone":50,"phoneExt":50,"email":50},"Marina Alvarez, MD","SUB_INVESTIGATOR",{"name":78,"role":76,"phone":50,"phoneExt":50,"email":50},"Mercedes Piqueras, PT",{"name":80,"role":76,"phone":50,"phoneExt":50,"email":50},"Ana V Lobato, PT",{"type":45,"investigatorFullName":82,"investigatorTitle":83,"investigatorAffiliation":5,"oldNameTitle":50,"oldOrganization":50},"Roser Belmonte","Rehabilitation specialist, MD, PhD","100551026","shock-wave-therapy-for-lower-limb-lymphedema-100551026",false,"NCT06454734","Shock Wave Therapy for Lower Limb Lymphedema","Lower Limb Lymphedema Treatment by Extracorporeal Shock Wave Therapy: Clinical Trial","Inclusion criteria\n\n* Patients with lower limb lymphedema\n* Lymphedema of at least 6 months of evolution\n* The lymphedema must affect at least the knee to the foot\n* Moderate or severe lymphedema (grades 2 or 3)\n* Sign the informed consent\n\nExclusion criteria\n\n* Under 18 years of age\n* Coagulation disorders (hemophilia, treatment with acenocoumarol, etc.)\n* Current or previous deep vein thrombosis of the lower extremity\n* Pregnancy\n* Electronic implantable medical devices as pacemaker implants, medication pumps, etc\n* Having received treatment with complex decongestive therapy or shock waves during the last 6 months\n* Treatment with corticosteroids or radiotherapy in the area to be treated in the last 6 weeks\n* Active oncological disease in the area to be treated\n* Active infectious-inflammatory process in the area to be treated\n* Cognitive or sensory deficits that prevent collaboration\n* Inability to walk independently or inability to attend therapy","ALL","18 Years",{"count":94,"type":95},30,"ESTIMATED","INTERVENTIONAL",[98],"NA","This is a double-blind randomized clinical trial to compare the effect of shock wave therapy on lower limb lymphedema. There are two arms: A) complex decongestive therapy + extracorporeal shock waves therapy; B) complex decongestive therapy plus placebo extracorporeal shock waves.",[101],"Lymphedema, Lower Limb","2025-07-30",{"date":104,"type":105},"2025-07-31","ACTUAL",{"date":107,"type":105},"2024-05-28",{"date":109,"type":95},"2026-12",{"name":5,"class":6},1]